Gene expression-based predictive models of graft versus host disease-associated dry eye

Investigative Ophthalmology and Visual Science

Volumn 56, Issue 8, 2015, Pages 4570-4581

  Cocho, Lidia ^a   Fernández, Itziar ^a,b   Calonge, Margarita ^a,b   Martínez, Verónica ^a   González García, María J ^a,b   Caballero, Dolores ^c   López Corra, Lucía ^c   García Vázquez, Carmen ^a   Vázquez, Lourdes ^c   Stern, Michael E ^d   Enríquez De Salamanca, Amalia ^a,b  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^d ALLERGAN INC   (United States)

Author keywords

Biomarker; Conjunctiva; Cytokine; Dry eye disease; Gene expression; Graft versus host disease; Keratoconjunctivitis sicca; Ocular GvHD

Indexed keywords

EOTAXIN 2; EPIDERMAL GROWTH FACTOR RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 9; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; BIOLOGICAL MARKER; CYTOKINE; EGFR PROTEIN, HUMAN; EYE PROTEIN; IL6 PROTEIN, HUMAN; IL9 PROTEIN, HUMAN; MESSENGER RNA; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE, HUMAN;

ADULT; AGED; ALGORITHM; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONJUNCTIVA; CONTROLLED STUDY; DRY EYE; FEMALE; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMPRESSION CYTOLOGY; K NEAREST NEIGHBOR; MALE; MATHEMATICAL MODEL; MEASUREMENT ACCURACY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; RNA ISOLATION; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINE; BIOLOGICAL MODEL; DRY EYE SYNDROMES; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; GRAFT VS HOST DISEASE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; QUESTIONNAIRE;

ADULT; AGED; BIOLOGICAL MARKERS; CONJUNCTIVA; CYTOKINES; DRY EYE SYNDROMES; EPITHELIAL CELLS; EYE PROTEINS; FEMALE; GENE EXPRESSION REGULATION; GRAFT VS HOST DISEASE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-9; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; QUESTIONNAIRES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84939624859     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.15-16736     Document Type: Article

References (70)

1. Hessen M, Akpek E. Ocular graft-versus-host disease. Curr Opin Allergy Clin Immunol. 2012;12:540-547.
2. Shikari H, Antin JH, Dana R. Ocular graft-versus-host disease: a review. Surv Ophthalmol. 2013;58:233-251.
3. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11:945-956.
4. Arnaout K, Patel N, Jain M, El-Amm J, Amro F, Tabbara IA. Complications of allogeneic hematopoietic stem cell transplantation. Cancer Invest. 2014;32:349-362.
5. Riemens A, Boome L, Imhof S, Kuball J, Rothova A. Current insights into ocular graft-versus-host disease. Curr Opin Ophthalmol. 2010;21:485-494.
6. de la Parra-Colín P, Agahan AL, Pérez-Simón JA, et al. Dry eye disease in chronic graft-versus-host disease: results from a Spanish retrospective cohort study. Transplant Proc. 2011;43: 1934-1938.
7. Nassar A, Tabbara KF, Aljurf M. Ocular manifestations of graftversus-host disease. Saudi J Ophthalmol. 2013;27:215-222.
8. Ogawa Y, Okamoto S, Wakui M, et al. Dry eye after haematopoietic stem cell transplantation. Br J Ophthalmol. 1999;83:1125-1130.
9. Macri A, Pflugfelder S. Correlation of the Schirmer 1 and fluorescein clearance tests with the severity of corneal epithelial and eyelid disease. Arch Ophthalmol. 2000;118: 1632-1638.
10. Dry Eye WorkShop (DEWS). Methodologies to diagnose and monitor dry eye disease: report of the diagnostic methodology. Ocul Surf. 2007;5:108-152.
11. Tatematsu Y, Ogawa Y, Abe T, et al. Grading criteria for chronic ocular graft-versus-host disease: comparing the NIH eye score, Japanese dry eye score, and DEWS 2007 score. Sci Rep. 2014; 4:6680.
12. Stern ME, Gao J, Siemasko KF, Beuerman RW, Pflugfelder SC. The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp Eye Res. 2004;78:409-416.
13. Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sj¨ogren’s syndrome keratoconjunctivitis sicca. Curr Eye Res. 1999;19:201-211.
14. Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci. 2001;42:2283-2292.
15. Kawasaki S, Kawamoto S, Yokoi N, et al. Up-regulated gene expression in the conjunctival epithelium of patients with Sj¨ogren’s syndrome. Exp Eye Res. 2003;77:17-26.
16. Narayanan S, Miller WL, McDermott AM. Conjunctival cytokine expression in symptomatic moderate dry eye subjects. Invest Ophthalmol Vis Sci. 2006;47:2445-2450.
17. De Paiva CS, Chotikavanich S, Pangelinan SB, et al. IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol. 2009;2:243-253.
18. Lam H, Bleiden L, de Paiva CS, Farley W, Stern ME, Pflugfelder SC. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol. 2009;147:198-205.
19. Enríquez de Salamanca A, Castellanos E, Stern ME, et al. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol Vis. 2010;16:862-873.
20. Boehm N, Riechardt AI, Wiegand M, Pfeiffer N, Grus FH. Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays. Invest Ophthalmol Vis Sci. 2011;52:7725-7730.
21. Paczesny S, Raiker N, Brooks S, Mumaw C. Graft-versus-host disease biomarkers: omics and personalized medicine. Int J Hematol. 2013;98:275-292.
22. Westekemper H, Meller S, Citak S, et al. Differential chemokine expression in chronic GVHD of the conjunctiva. Bone Marrow Transplant. 2010;45:1340-1346.
23. Tesón M, González-García MJ, López-Miguel A, et al. Influence of a controlled environment simulating an in-flight airplane cabin on dry eye disease. Invest Ophthalmol Vis Sci. 2013;54: 2093-2099.
24. López-Miguel A, Tesón M, Martín-Montañez V, et al. Dry eye exacerbation in patients exposed to desiccating stress under controlled environmental conditions. Am J Ophthalmol. 2014; 157:788-798.
25. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118:615-621.
26. Efron N, Morgan PB, Jagpal R. Validation of computer morphs for grading contact lens complications. Ophthalmic Physiol Opt. 2002;22:341-349.
27. Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22:640-650.
28. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80.
29. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3:research0034.1-research0034.11.
30. Perkins JR, Dawes JM, McMahon SB, et al. ReadqPCR and NormqPCR: R packages for the reading, quality checking and normalisation of RT-qPCR quantification cycle (Cq) data. BMC Genomics. 2012;13:296.
31. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:Article3.
32. Dvinge H, Bertone P. HTqPCR: high-throughput analysis and visualization of quantitative real-time PCR data in R. Bioinformatics. 2009;25:3325-3326.
33. Ding C, Peng H. Minimum redundancy feature selection from microarray gene expression data. J Bioinform Comput Biol. 2005;3:185-205.
34. Ahdesmäki M, Zuber V, Gibb S, Strimmer K. Sda: Shrinkage Discriminant Analysis and CAT Score Variable Selection. R package version 1.3.4. 2014. http://CRAN.R-project.org/package=sda.
35. Vapnik V. Methods of Function Estimation. The Nature of Statistical Learning Theory. 2nd ed. New York: Springer- Verlag; 2000:181-216.
36. Meyer D, Dimitriadou E, Hornik K, Weingessel A, Leisch F. e1071: Misc Functions of the Department of Statistics (e1071). 2014; Wien TU. R package version 1.6-4. http://cran.r-project.org/web/packages/e1071/.
37. Webb AR. Statistical Pattern Recognition. 2nd ed. West Sussex, UK: John Wiley and Sons; 2002:93-104.
38. Venables WN, Ripley BD. Modern Applied Statistics with S. 4th ed. New York: Springer; 2002:331-352.
39. Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21:128-138.
40. Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and Sþ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.
41. Rozmus J, Schultz KR, Wynne K, et al. Early and late extensive chronic graft-versus-host disease in children is characterized by different Th1/Th2 cytokine profiles: findings of the Children’s Oncology Group Study ASCT0031. Biol Blood Marrow Transplant. 2011;17:1804-1813.
42. Hayashida JN, Nakamura S, Toyoshima T, et al. Possible involvement of cytokines, chemokines and chemokine receptors in the initiation and progression of chronic GVHD. Bone Marrow Transplant. 2013;48:115-123.
43. Paczesny S, Krijanovski OI, Braun TM, et al. A biomarker panel for acute graft-versus-host disease. Blood. 2009;113:273-278.
44. Paczesny S, Braun T, Vander Lugt A, Harris B, Fiema J, Hernandez J. A three biomarker panel at days 7 and 14 can predict development of grade II-IV acute graft-versus-host disease. Biol Blood Marrow Transplant. 2011;17:S167.
45. DiCarlo J, Agarwal-Hashmi R, Shah A, et al. Cytokine and chemokine patterns across 100 days after hematopoietic stem cell transplantation in children. Biol Blood Marrow Transplant. 2014;20:361-369.
46. Kaiser T, Kamal H, Rank A, et al. Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation. Blood. 2004;104:340-349.
47. Pang H, Tong T, Zhao H. Shrinkage-based diagonal discriminant analysis and its applications in high-dimensional data. Biometrics. 2009;65:1021-1029.
48. Brand TM, Iida M, Luthar N, Starr MM, Huppert EJ, Wheeler DL. Nuclear EGFR as a molecular target in cancer. Radiother Oncol. 2013;108:370-377.
49. Zieske JD, Takahashi H, Hutcheon AE, Dalbone AC. Activation of epidermal growth factor receptor during corneal epithelial migration. Invest Ophthalmol Vis Sci. 2000;41:1346-1355.
50. Márquez EB, De Ortueta D, Royo SB, Martínez-Carpio PA. Epidermal growth factor receptor in corneal damage: update and new insights from recent reports. Cutan Ocul Toxicol. 2011;30:7-14.
51. Na KS, Mok JW, Kim JY, Rho CR, Joo CK. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease. Invest Ophthalmol Vis Sci. 2012; 53:5443-5450.
52. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The proand anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. 2011;1813:878-888.
53. Enríquez-de-Salamanca A, Calder V, Gao J, et al. Cytokine responses by conjunctival epithelial cells: an in vitro model of ocular inflammation. Cytokine. 2008;44:160-167.
54. Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4þCD25þ T cell-mediated suppression by dendritic cells. Science. 2003;299:1033-1036.
55. Chen X, Das R, Komorowski R, et al. Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease. Blood. 2009; 114:891-900.
56. Tawara I, Koyama M, Liu C, et al. Interleukin-6 modulates graftversus- host responses after experimental allogeneic bone marrow transplantation. Clin Cancer Res. 2011;17:77-88.
57. Toubai T, Tanaka J, Paczesny S, et al. Role of cytokines in the pathophysiology of acute graft-versus-host disease (GVHD): are serum/plasma cytokines potential biomarkers for diagnosis of acute GVHD following allogeneic hematopoietic cell transplantation (Allo-HCT)? Curr Stem Cell Res Ther. 2012;7: 229-239.
58. Min CK, Lee WY, Min DJ, et al. The kinetics of circulating cytokines including IL-6, TNF-alpha, IL-8 and IL-10 following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;28:935-940.
59. Fujii N, Hiraki A, Aoe K, et al. Serum cytokine concentrations and acute graft-versus-host disease after allogeneic peripheral blood stem cell transplantation: concurrent measurement of ten cytokines and their respective ratios using cytometric bead array. Int J Mol Med. 2006;17:881-885.
60. Riemens A, Stoyanova E, Rothova A, Kuiper J. Cytokines in tear fluid of patients with ocular graft-versus-host disease after allogeneic stem cell transplantation. Mol Vis. 2012;18:797-802.
61. Schots R, Kaufman L, Van Riet I, et al. Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation. Leukemia. 2003;17: 1150-1156.
62. Goswami R, Kaplan MH. A brief history of IL-9. J Immunol. 2011;186:3283-3288.
63. Tan C, Gery I. The unique features of Th9 cells and their products. Crit Rev Immunol. 2012;32:1-10.
64. Tawara I, Maeda Y, Sun Y, et al. Combined Th2 cytokine deficiency in donor T cells aggravates experimental acute graft-vs-host disease. Exp Hematol. 2008;36:988-996.
65. Sun Z, Lei H, Zhang Z. Pre-B cell colony enhancing factor (PBEF), a cytokine with multiple physiological functions. Cytokine Growth Factor Rev. 2013;24:433-442.
66. Romacho T, Sánchez-Ferrer CF, Peiró C. Visfatin/Nampt: an adipokine with cardiovascular impact. Mediators Inflamm. 2013;2013:1-15.
67. Bruzzone S, Fruscione F, Morando S, et al. Catastrophic NADþ depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE. PLoS One. 2009;4:e7897.
68. Ramaswamy S, Tamayo P, Rifkin R, et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A. 2001;98:15149-15154.
69. Kohrt HE, Tian L, Li L, et al. Identification of gene microarray expression profiles in patients with chronic graft-versus-host disease following allogeneic hematopoietic cell transplantation. Clin Immunol. 2013;148:124-135.
70. Paczesny S, Hakim FT, Pidala J, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: III. The 2014 Biomarker Working Group Report. Biol Blood Marrow Transplant. 2015;21:780-792.